Effect of treatment and change of islet function by adding insulin glargine on patients with second failure of sulfonylureas
- VernacularTitle:磺脲类继发失效糖尿病患者加用胰岛素疗效及胰岛B细胞功能变化
- Author:
Yunhong HUANG
;
Yun JIANG
;
Yijie WU
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus;
Sulfonylureas;
Second failure;
Insulin glargine;
Islet function
- From:
Chinese Journal of Practical Internal Medicine
2001;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of insulin glaring(IG)and neutral protamine hagedorn(NPH)on metabolic control and islet cell function in type 2 diabetic patients who secondly failed to sulfonylureas(SU)treatment.Methods Fifty-two diabetic patients with second SU failure were studied in our hospital during May,2004 to Nov,2004,and they were divided into two groups:twenty treated with glipizide extended release tablets(GERT)plus IG injection,while thirty-two with GERT plus NPH.Fasting and postprandial blood glucose,HbA_1c,fasting and postprandial C-peptide were determined in all patients at different following points.Results Blood glucose decreased obviously and similarly in two groups;however,hypoglycemia occurred less in IG group.Interestingly,fasting and postprandial C-peptide significantly increased in IG group,but didn't change in NPH group.Conclusion Combination treatment with IG or NPH has good effect on metabolic control in second SU failure patients;and moreover,IG improves B-cell function.
